Search for: "H R B Technology L L C" Results 141 - 160 of 244
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2017, 10:13 pm by W.F. Casey Ebsary, Jr.
 On a school bus or in a vehicle, aircraft, or motorboat. 145 (l)(h) “Qualifying Qualified patient” has the same meaning 146 as provided in s. 29, Art. [read post]
25 Jan 2017, 10:13 pm by W.F. Casey Ebsary, Jr.
 On a school bus or in a vehicle, aircraft, or motorboat. 145 (l)(h) “Qualifying Qualified patient” has the same meaning 146 as provided in s. 29, Art. [read post]
23 Dec 2015, 12:00 am by Mark Meyer
By Michaela Oldfield / Global Research FellowAs I noted in my post on FDA’s approval of AquaAdvantage, the labelling of foods is a major hot-button issue in the current controversy over genetic engineering technologies and our food system. [read post]
10 Oct 2018, 11:22 am by Inu Manak
Each regulation identified in the list should be accompanied by: (a)  a concise description of the planned regulation; (b)  a point of contact for a knowledgeable person in the regulatory authority responsible for the regulation; and (c)  an indication, if known, of sectors to be affected and whether there is any expected significant effect on international trade or investment. [read post]
2 Jun 2008, 1:33 am
Appropriations made by this act shall remain in full force and effect for liabilities incurred through 3/31/2009 PART B §18. immediately and shall be deemed to have been in full force and effect on and after 4/1/2007. [read post]
18 Apr 2008, 2:00 am
: (Spicy IP), India: OPPI recommends timeframe for pre-grant opposition: (Spicy IP), India: Jatropha patents (agri-biotech): (Spicy IP), India & US: Stem cell patents: (Spicy IP), Kenya: GSK presses Kenya to crack down on imports of fake medicines: (Afro-IP), Nigeria: Interview with Director General of NAFDAC - Cracking down on counterfeit drugs: (Afro-IP), EU: No link between parallel trade and reduction in R&D, says AG in Sot. [read post]
5 Oct 2017, 3:33 pm by Daphne Keller
The Commission’s discussion of filtering technology is at best magical thinking, and at worst cynically disingenuous. [read post]
29 Jul 2010, 9:48 pm by David M. McLain
Sandgrund and Sullan.Reproduced by permission of the Colorado Bar Association Vol. 39, August, 2010, pg. 89-96, (c) Colorado Bar Association 2010. [read post]
12 Sep 2010, 10:56 am
(l) "Pharmacy services" shall mean the preparing, compounding, preserving or, the dispensing of drugs, medicines and therapeutic devices on the basis of prescriptions or other legal authority. [read post]
20 May 2019, 9:11 am by MOTP
 It has been suggested that the focus of inquiry in the Restatement project should be on decisions of state courts of last resort (and that overruled cases should be disregarded because they are no longer “good law” which makes eminent sense from the viewpoint of legal practice and appellate advocacy but less so from a more comprehensive view of the evolution of the substance of the law in historical context, which should also pay heed to dissents).The courts of law resort decide a… [read post]
22 Oct 2018, 8:05 am by Mary
(2)No reproduction, distribution, display, or performance is authorized under this subsection if - (A) the work is subject to normal commercial exploitation; (B) a copy or phonorecord of the work can be obtained at a reasonable price; or (C) the copyright owner or its agent provides notice pursuant to regulations promulgated by the Register of Copyrights that either of the conditions set forth in subparagraphs (A) and (B) applies [read post]
22 Oct 2018, 8:05 am by Mary
(2)No reproduction, distribution, display, or performance is authorized under this subsection if - (A) the work is subject to normal commercial exploitation; (B) a copy or phonorecord of the work can be obtained at a reasonable price; or (C) the copyright owner or its agent provides notice pursuant to regulations promulgated by the Register of Copyrights that either of the conditions set forth in subparagraphs (A) and (B) applies [read post]
4 Mar 2019, 10:36 am by Lev Sugarman
Panelists include Jung H. [read post]